MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 2 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,035,000 | +177.5% | 44,432 | 0.0% | 0.16% | +312.5% |
Q1 2020 | $373,000 | -11.2% | 44,432 | +3.3% | 0.04% | +60.0% |
Q4 2019 | $420,000 | +2.9% | 43,032 | 0.0% | 0.02% | +4.2% |
Q3 2019 | $408,000 | -15.7% | 43,032 | +5.6% | 0.02% | -17.2% |
Q2 2019 | $484,000 | -15.4% | 40,732 | +25.5% | 0.03% | -12.1% |
Q1 2019 | $572,000 | -15.9% | 32,457 | -17.1% | 0.03% | -21.4% |
Q4 2018 | $680,000 | +21.0% | 39,147 | +3.7% | 0.04% | +40.0% |
Q3 2018 | $562,000 | -5.9% | 37,735 | +0.5% | 0.03% | -11.8% |
Q2 2018 | $597,000 | +9.5% | 37,535 | -2.2% | 0.03% | +6.2% |
Q1 2018 | $545,000 | +1.5% | 38,390 | 0.0% | 0.03% | -5.9% |
Q4 2017 | $537,000 | – | 38,390 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |